Angeles Wealth Management LLC Grows Stock Holdings in HCA Healthcare, Inc. $HCA

Angeles Wealth Management LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 15.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 990 shares of the company’s stock after buying an additional 133 shares during the period. Angeles Wealth Management LLC’s holdings in HCA Healthcare were worth $379,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in HCA. Nuveen LLC purchased a new stake in HCA Healthcare during the first quarter worth $569,217,000. Pacer Advisors Inc. boosted its holdings in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after buying an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after buying an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. raised its position in HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after acquiring an additional 587,036 shares during the period. Finally, Abdiel Capital Advisors LP acquired a new position in HCA Healthcare during the first quarter worth $164,835,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 1.4%

Shares of HCA opened at $425.50 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01. The firm has a 50-day moving average price of $410.05 and a 200 day moving average price of $378.21. The firm has a market capitalization of $99.56 billion, a P/E ratio of 17.89, a P/E/G ratio of 1.33 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Analysts Set New Price Targets

HCA has been the subject of a number of research analyst reports. The Goldman Sachs Group initiated coverage on shares of HCA Healthcare in a research report on Tuesday. They set a “buy” rating and a $470.00 price objective for the company. Mizuho upped their price objective on shares of HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a research report on Friday. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 7th. Bank of America increased their target price on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research report on Wednesday, September 10th. Finally, Morgan Stanley reduced their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $434.00.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.